0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Erythroleukemia (di Guglielmo Syndrome):  A Report of Clinical Observations and Experimental Studies in Seven Patients

RAYMOND F. SHEETS, M.D.; CURTIS C. DREVETS, M.D.; HENRY E. HAMILTON, M.D.
Arch Intern Med. 1963;111(3):295-306. doi:10.1001/archinte.1963.03620270021004.
Text Size: A A A
Published online

Discussion of a curious disease of the blood was begun by Copelli1 in 1912 and continued by di Guglielmo.2,3 Dameshek and Gunz5 called it the "di Guglielmo syndrome" and defined it as a "myeloproliferative disorder." According to their concept, alterations in the bone marrow in erythroleukemia may pass through 3 phases if the patient lives long enough. The first phase is characterized by a preponderant erythroblastic proliferation with relatively minimal myeloblastic proliferation which is similar in description to di Guglielmo's3 "erythremic myelosis." The second stage is reached when the myeloblasts increase, and the term "erythroleukemia" becomes more appropriate. Presumably most patients come under observation during this phase. In the third and usually terminal phase, the "myeloblasts" become dominant and the bone marrow picture is similar to the blast crisis of acute or chronic myelocytic leukemia. Few published reports give data on these phases, and many are

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 25

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();